Attacking c-Myc: Targeted and Combined Therapies for Cancer

By  

Current Pharmaceutical Design, Vol. 20, Iss. 42, 2014-12 ,pp. : 6543-6554

Bentham Science Publishers

Access to resources Recommend Favorite

A Cyclometallated Iridium(III) Complex As a c-myc G-Quadruplex Stabilizer and Down-Regulator of c-myc Oncogene Expression

By  

Current Medicinal Chemistry, Vol. 20, Iss. 4, 2013-02 ,pp. : 576-582

Bentham Science Publishers

Access to resources Recommend Favorite

The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth

By Pelengaris Stella   Khan Mike  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 5, 2003-10 ,pp. : 623-642

Informa Healthcare

Access to resources Recommend Favorite

Plant alkaloid tetrandrine downregulates protein kinase C-dependent signaling pathway in T cells

By Ho L.-J.   Chang D.-M.   Lee T.-C.   Chang M.-L.   Lai J.-H.  

European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. : 389-398

Elsevier

Access to resources Recommend Favorite

ZnCl 2 prevents c-myc repression and apoptosis in serum-deprived Syrian hamster embryo cells

By Alexandre S.   Rast C.   Nguyen-Ba G.   Vasseur P.  

Environmental Toxicology and Pharmacology, Vol. 11, Iss. 3, 2002-07 ,pp. : 191-196

Elsevier

Access to resources Recommend Favorite